The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Risk of Melanoma and Nonmelanoma Skin Cancer Among Patients With Inflammatory Bowel Disease
Open accessAbstract
BACKGROUND & AIMS Patients with inflammatory bowel disease (IBD) are at risk for certain malignancies. We aimed to determine the risk of melanoma and nonmelanoma skin cancer (NMSC) in patients with IBD and how medications affect these risks. METHODS We performed retrospective cohort and nested case-control studies using administrative data from the LifeLink Health Plan Claims Database from 1997 to 2009. The cohort comprised 108,579 patients with IBD, and each was matched to 4 individuals without IBD. The risk of melanoma and NMSC was evaluated by incidence rate ratio (IRR) and by adjusted Cox proportional hazard ratio (HR) modeling. In nested case-control studies, patients with melanoma or NMSC were matched to 4 patients with IBD without melanoma or NMSC. Conditional logistic regression was used to determine associations between medications and both skin cancers. RESULTS In the cohort, IBD was associated with an increased incidence of melanoma (IRR, 1.29; 95% confidence interval [CI], 1.09–1.53). Risk was greatest among individuals with Crohn’s disease (IRR, 1.45; 95% CI, 1.13–1.85; adjusted HR, 1.28; 95% CI, 1.00–1.64). The incidence of NMSC also increased among patients with IBD (IRR, 1.46; 95% CI, 1.40–1.53) and was greatest among those with CD (IRR, 1.64; 95% CI, 1.54–1.74). In the nested case-control studies, therapy with biologics increased the risk of melanoma (odds ratio [OR], 1.88; 95% CI, 1.08–3.29). Patients who had been treated with thiopurines had an increased risk of NMSC (OR, 1.85; 95% CI, 1.66–2.05). CONCLUSIONS Immunosuppression increases the risk of melanoma and NMSC among patients with IBD. The risk of melanoma is increased by use of biologics, and the risk of NMSC is increased by use of thiopurines. Patients with IBD should be counseled and monitored for skin cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
DEYO, R. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90133-8 · Cited by 10,452
Skin cancers after organ transplantation
Euvrard, S., Kanitakis, J., & Claudy, A. (2003) · New England Journal of Medicine · doi:10.1056/nejmra022137 · Cited by 1,575
Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006
Rogers, H. W., Weinstock, M. A., Harris, A. R., Hinckley, M. R., Feldman, S. R., Fleischer, A. B., & Coldiron, B. M. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.19 · Cited by 1,185
Cancer risk in patients with inflammatory bowel disease: A population-based study
Bernstein, C. N., Blanchard, J. F., Kliewer, E., & Wajda, A. (2001) · Cancer · doi:10.1002/1097-0142(20010215)91:4<854::aid-cncr1073>3.0.co;2-z · Cited by 1,165
Kappelman, M. D., Rifas–Shiman, S. L., Kleinman, K., Ollendorf, D., Bousvaros, A., Grand, R. J., & Finkelstein, J. A. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.07.012 · Cited by 932
Self-citationThe pathogenesis of melanoma induced by ultraviolet radiation
Gilchrest, B. A., Eller, M. S., Geller, A. C., & Yaar, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904293401707 · Cited by 876
Jensen, P., Hansen, S., Møller, B., Leivestad, T., Pfeffer, P., Geiran, O., Fauchald, P., & Simonsen, S. (1999) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(99)70185-4 · Cited by 871
Melanoma and sun exposure: An overview of published studies
Elwood, J. M., & Jopson, J. (1997) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19971009)73:2<198::aid-ijc6>3.0.co;2-r · Cited by 791
Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management
Berg, D., & Otley, C. C. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.125579 · Cited by 723
Azathioprine and UVA Light Generate Mutagenic Oxidative DNA Damage
O'Donovan, P., Perrett, C. M., Zhang, X., Montaner, B., Xu, Y.-Z., Harwood, C. A., McGregor, J. M., Walker, S. L., Hanaoka, F., & Karran, P. (2005) · Science · doi:10.1126/science.1114233 · Cited by 631
Wolfe, F., & Michaud, K. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22864 · Cited by 534
Siegel, C. A., Marden, S. M., Persing, S. M., Larson, R. J., & Sands, B. E. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.01.004 · Cited by 511
Peyrin–Biroulet, L., Khosrotehrani, K., Carrat, F., Bouvier, A., Chevaux, J., Simon, T., Carbonnel, F., Colombel, J., Dupas, J., Godeberge, P., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.050 · Cited by 490
The epidemiology of inflammatory bowel disease: A large, population-based study in Sweden
Ekbom, A., Helmick, C., Zack, M., & Adami, H.-O. (1991) · Gastroenterology · doi:10.1016/0016-5085(91)90202-v · Cited by 441
Mariette, X., Matucci-Cerinic, M., Pavelka, K., Taylor, P., van Vollenhoven, R., Heatley, R., Walsh, C., Lawson, R., Reynolds, A., & Emery, P. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.149419 · Cited by 404
Increased Risk for Non-Melanoma Skin Cancer in Patients With Inflammatory Bowel Disease
Long, M. D., Herfarth, H. H., Pipkin, C. A., Porter, C. Q., Sandler, R. S., & Kappelman, M. D. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.11.024 · Cited by 306
Self-citationPedersen, N., Duricova, D., Elkjaer, M., Gamborg, M., Munkholm, P., & Jess, T. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.760 · Cited by 277
Tumor necrosis factor α antagonist use and cancer in patients with rheumatoid arthritis
Setoguchi, S., Solomon, D. H., Weinblatt, M. E., Katz, J. N., Avorn, J., Glynn, R. J., Cook, E. F., Carney, G., & Schneeweiss, S. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22056 · Cited by 240
Incidence and Risk Factors for Herpes Zoster Among Patients With Inflammatory Bowel Disease
Gupta, G., Lautenbach, E., & Lewis, J. D. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.019 · Cited by 208
Increased Risk of Nonmelanoma Skin Cancers Among Individuals With Inflammatory Bowel Disease
Singh, H., Nugent, Z., Demers, A. A., & Bernstein, C. N. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.039 · Cited by 164
A Population-based Ecologic Study of Inflammatory Bowel Disease: Searching for Etiologic Clues
Green, C. A., Elliott, L. J., Beaudoin, C. M., & Bernstein, C. N. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj260 · Cited by 148
Chaudru, V., Chompret, A., Paillerets, B. B., Spatz, A., Avril, M.-F., & Démenais, F. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh136 · Cited by 105
Herrinton, L. J., Liu, L., Lafata, J. E., Allison, J. E., Andrade, S. E., Korner, E. J., Chan, K. A., Platt, R. G., Hiatt, D. C., & O’Connor, S. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20021 · Cited by 98
Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies
Fulchiero, G. J., Salvaggio, H. L., Drabick, J. J., Staveley-O’Carroll, K. F., Billingsley, E. M., Marks, J. G., & Helm, K. F. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.12.024 · Cited by 87
Singh, S. D., Ajani, U. A., Johnson, C. J., Roland, K. B., Eide, M. J., Jemal, A., Negoita, S., Bayakly, R. A., & Ekwueme, D. U. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.05.035 · Cited by 84
Stempel, D. A., Mauskopf, J., McLaughlin, T., et al. (2001) · Respiratory Medicine · doi:10.1053/rmed.2000.1027 · Cited by 74
Nonmelanoma skin cancer in inflammatory bowel disease: A review
Long, M. D., Kappelman, M. D., & Pipkin, C. A. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21484 · Cited by 64
Self-citationLatitude gradients in melanoma incidence and mortality in the non-Maori population of New Zealand
Bulliard, J., Cox, B., & Elwood, M. (1994) · Cancer Causes & Control · doi:10.1007/bf01830242 · Cited by 63
Flasar, M. H., Johnson, T. J., Roghmann, M., & Cross, R. K. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20298 · Cited by 63
Immunosuppression, Skin Cancer, and Ultraviolet A Radiation
Parrish, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmcibr054224 · Cited by 54
Katsanos, K. H., Vermeire, S., Christodoulou, D. K., Riis, L. B., Wolters, F. J., Odes, S. H., Freitas, J., Høie, O., Beltrami, M., Fornaciari, G., et al. (2007) · Digestion · doi:10.1159/000104731 · Cited by 54
Suboptimal Rates of Cervical Testing Among Women With Inflammatory Bowel Disease
Long, M. D., Porter, C. Q., Sandler, R. S., & Kappelman, M. D. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.10.007 · Cited by 45
Self-citationLund, J. L., Stürmer, T., Porter, C. Q., Sandler, R. S., & Kappelman, M. D. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21348 · Cited by 16
Self-citationMesalazine and Photosensitivity
Horiuchi, Y., & Shimakura, S. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.03386.x · Cited by 11
Bigby, M. E. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.171 · Cited by 8
Cited by
Ungaro, R., Mehandru, S., Allen, P. B., Peyrin-Biroulet, L., & Colombel, J.-F. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,531
Cancers Complicating Inflammatory Bowel Disease
Beaugerie, L., & Itzkowitz, S. H. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403718 · Cited by 678
Crohn Disease: Epidemiology, Diagnosis, and Management
Feuerstein, J. D., & Cheifetz, A. S. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.04.010 · Cited by 548
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis
Timmer, A., Patton, P. H., Chande, N., McDonald, J. W., & MacDonald, J. K. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000478.pub4 · Cited by 528
ACG clinical guideline: Preventive care in inflammatory bowel disease
Farraye, F. A., Melmed, G. Y., Lichtenstein, G. R., & Kane, S. V. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2016.537 · Cited by 473
Metadata
- Authors
- Long, M. D., Martin, C. F., Pipkin, C. A., Herfarth, H. H., Sandler, R. S., & Kappelman, M. D.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 143
- Issue
- 2
- Pages
- 390-399.e1
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2080450248
- Cited by
- 526
- References
- 37
- FWCI
- 28.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.